Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding
Launched by FAR EASTERN MEMORIAL HOSPITAL · Jan 23, 2011
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
as brief summary
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • gastroduodenal ulcer with bleeding, documented by endoscopic examination
- Exclusion Criteria:
- • 1. receiving continuous proton pump inhibitor treatment, antibiotics within 4 weeks 2. not suitable for endoscopic biopsy 3. hemodynamically unstable
About Far Eastern Memorial Hospital
Far Eastern Memorial Hospital is a leading healthcare institution in Taiwan, renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, the hospital integrates cutting-edge technology and evidence-based practices to conduct rigorous clinical studies across various therapeutic areas. Far Eastern Memorial Hospital prioritizes patient safety and ethical standards, ensuring that all trials are designed to enhance medical knowledge and contribute to the development of new treatments. Its experienced team of researchers and healthcare professionals is dedicated to fostering a research environment that supports scientific discovery and enhances health outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Taipei City, , Taiwan
Patients applied
Trial Officials
Tzong-Hsi Lee, MD
Principal Investigator
Far Eastern Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials